Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis
Sign Up to like & getrecommendations! Published in 2023 at "Hepatology"
DOI: 10.1097/hep.0000000000000316
Abstract: Background and Aims: Patients with compensated cirrhosis with clinically significant portal hypertension (CSPH: HVPG >10 mm Hg) have a high risk of decompensation. HVPG is, however, an invasive procedure not available in all centers. The… read more here.
Keywords: risk decompensation; compensated cirrhosis; model; patients compensated ... See more keywords